Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-19-045684

Chief Commercial Officer bought 1,500 shares at $6.00 ($9,000)

From the SEC's structured data for this filing

Trades in this filing

Millian Craig Stuart · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-08-12 Purchase : show line 1 in the form +1,500 $6.00 $9,000 7,500 D
Open-market purchases · 1,500 sh · avg $6.00 · $9,000
Loading xslF345X03/doc4.xml…